Security key
28036F105
Edgewise Therapeutics, Inc. - Common Stock (EWTX)
CUSIP: 28036F105
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 64,390,889
- Total 13F value
- $633,608,275
- Share change
- +13,414,165
- SEC-reported price per share
- $9.84
- Number of holders
- 92
- Value change
- +$132,537,303
- Number of buys
- 57
- Number of sells
- 26
- Shares outstanding
- 107,555,564
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
92
Top holders
10
EWTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Edgewise Therapeutics, Inc. SEC filings
Edgewise Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 28036F105
Recent filing periods:
Ownership snapshot
Top reported holders of EWTX - Edgewise Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
14 Sep 2022
13F
3/4/5
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
13%
Novo Holdings A/S
5.2%
DEERFIELD MANAGEMENT COMPANY, L.P.
3.7%
Cormorant Asset Management, LP
3.6%
FMR LLC
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
13%
|
$112,098,000
14,082,680 shares
|
— | 30 Jun 2022 |
| Novo Holdings A/S |
3/4/5
13F
10%+ Owner · Company
|
5.2%
from 13F
|
$95,781,722
6,071,703 shares
|
— | 14 Sep 2022 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
3.7%
|
$31,308,000
3,933,137 shares
|
— | 30 Jun 2022 |
| Cormorant Asset Management, LP |
13F
Company
|
3.6%
|
$30,646,000
3,850,000 shares
|
— | 30 Jun 2022 |
| FMR LLC |
13F
Company
|
2.6%
|
$22,410,000
2,815,277 shares
|
— | 30 Jun 2022 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
2.5%
|
$21,709,000
2,727,249 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
92
Shares
64,390,889
Rows available
92
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
76
Q3 2022 holders
92
Holder diff
16
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend